• Jump to Header
  • Jump to Main Content
  • Jump to Footer
Michigan State University
Michigan State University
MSUToday
  • For Media
  • Experts
  • Releases and Statements
  • Sign Up
  • Update Information
MSUTODAY
  • Browse Stories By

    Topics

    Explore stories by subject area

    • Arts and Culture
    • Business and Economy
    • Climate and Environment
    • Education and Learning
    • Engineering, Science and Technology
    • Government and Society
    • Health and Medicine
    • Media and Communications
    • MSU Leadership and Impact
    • Sports and Recreation
    • Student and Campus Experience
    View All Stories

    Collections

    Curated story series

    • Alumni stories
    • Turfgrass
    • Ask the Expert
    • Big Ideas
    • Climate solutions
    • Water at MSU
    • Mobility
    • Spartan Perspectives
    • Student views
    • Graduate voices
    • Faculty voices
    View All Collections

    Featured

    Editor's picks

    • MSU earns top 100 ranking by Times Higher Education

      Oct. 12, 2026

      MSU earns top 100 ranking by Times Higher Education

    • New spaces, new opportunities at MSU 

      Oct. 14, 2026

      New spaces, new opportunities at MSU 

MSUTODAY
  • Browse Stories By

< Browse Stories By

Topics

Explore stories by subject area

  • Arts and Culture
  • Business and Economy
  • Climate and Environment
  • Education and Learning
  • Engineering, Science and Technology
  • Government and Society
  • Health and Medicine
  • Media and Communications
  • MSU Leadership and Impact
  • Sports and Recreation
  • Student and Campus Experience
  • View All Stories

Collections

Curated story series

  • Alumni stories
  • Turfgrass
  • Ask the Expert
  • Big Ideas
  • Climate solutions
  • Water at MSU
  • Mobility
  • Spartan Perspectives
  • Student views
  • Graduate voices
  • Faculty voices
  • View All Collections

Featured

Editor's picks

  • MSU earns top 100 ranking by Times Higher Education

    Oct. 12, 2026

    MSU earns top 100 ranking by Times Higher Education

  • New spaces, new opportunities at MSU 

    Oct. 14, 2026

    New spaces, new opportunities at MSU 

  • For Media
  • Experts
  • Releases and Statements
  • Sign Up
  • Update Information
Diseases, Conditions and Treatments

Oct. 20, 2026 | Read time 4 min

SHARE

MSU, Corewell Health expand rare disease research after breakthrough discovery

By: Dalin Clark

Summary

  • A groundbreaking discovery starting with a single Michigan child has unlocked life-changing treatment for rare genetic conditions worldwide.
  • A new $7.6 million grant from the National Institutes of Health aligns MSU and Corewell Health with an elite nationwide rare disease clinical research network to accelerate drug approvals and expand care for related rare conditions.
  • The landmark partnership proves that combining lab science with clinical care gives real answers, treatment options and hope to families facing unknown rare diseases. 

When Marley Berthoud was born in 2015, her mother and father, Kelly and Brian Berthoud, knew instantly that something was wrong. Marley suffered from low muscle tone, developmental delays, complete hair loss and difficulty regulating her blood sugar and body temperature.

For four years, her parents searched for answers as Marley remained nonverbal and unable to hold up her head or feed herself. The turning point came when genetic testing by Caleb Bupp at Corewell Health Helen DeVos Children’s Hospital and molecular research from André Bachmann at the Michigan State University College of Human Medicine identified a mutation in Marley’s ODC1 gene. This case established the first recognized diagnosis of Bachmann-Bupp syndrome.

Drawing on decades of protein research with ODC1, Bachmann identified an existing medication, difluoromethylornithine, or DFMO, which has long been used to treat West African sleeping sickness, to “turn down” Marley’s overactive protein. In late 2019, 4-year-old Marley became the first person in the world treated with DFMO for the condition.

As nurses, Kelly and Brian carefully weighed their options before taking the leap. And once they did, the results were dramatic. Within months, Marley’s hair, eyelashes and eyebrows grew back, and she sat up independently, gained strength and made major cognitive strides. Today, 11-year-old Marley communicates using an iPad, follows commands and brightens every room she enters with her big smile.

This historic milestone proved that bridging the gap between laboratory research and bedside care could open new doors for families of children with rare diseases who felt like they had no medical options. This important alignment was recently recognized by the National Institutes of Health, or NIH, with a new $7.6 million NIH U54 grant awarded jointly to the MSU College of Human Medicine and Corewell Health.

The importance of researcher-physician partnerships

Full-length portrait of Dr. Caleb Bupp (left) and Dr. André Bachmann (right) standing side by side in a modern glass skywalk with white geometric structural beams. Dr. Bupp is wearing a navy blue suit with a light plaid tie, glasses, and a full beard with his hands in his pockets. Dr. Bachmann is wearing a dark suit with a green patterned tie and arms crossed.
Dr. Caleb Bupp (left) and Dr. André Bachmann (right). Photo credit: Johnny Quirin.

“I’m a scientist and university professor, not a physician,” Bachmann said. “There is no way I could do this without Dr. Bupp and his team at Corewell Health because they are the ones who care for the patients. But at the same time, they could never have done this without our academic laboratory expertise. It is a mutually beneficial partnership, and neither of us would have achieved this alone.”

Translating years of lab experiments into real-world patient progress brought a profound sense of purpose to the entire research team.

“It is so fulfilling when you see your laboratory research translate directly into helping a child at the clinic,” Bachmann added. “When we first saw Marley, she had no muscle tone, couldn’t sit up and needed a feeding tube. Today, she is communicating, taking steps and enjoying her life. Seeing a safe medication bring back a child’s strength and hair — and giving her family hope — goes beyond anything we could have imagined. This new grant lets us expand that hope to families everywhere with children who have Bachmann-Bupp Syndrome or related polyamine disorders.”

Bupp agreed that starting with one child’s story created a ripple effect that could help countless other families navigating rare genetic diagnoses.

“All of this work has been so rewarding because it started with a single patient, which is my favorite way to do research,” he said. “From a human standpoint, I don’t think there’s a better way to spend research funds than on rare diseases because what you learn in rare diseases, you can then expand to help so many others. This new grant comes at a beautiful point for us to take what we have built together over almost 10 years and change the direction steeply toward expanding this to help more patients and families.”

For Kelly and Brian, seeing Marley thrive has given their family a level of peace they once thought was impossible.

“I wholeheartedly believe that Marley’s comprehension would not be at the level we’re seeing today without this medication,” Kelly shared. “As a parent, I know without a doubt that she’s happy she’s here and she enjoys her life. I could not ask for anything more.”

Expanding research, care to help more kids and families

The new funding will further support the existing Center for Polyamine Disorders, or CPD, which was founded by Bachmann and Bupp in 2017. The grant also welcomes MSU, Corewell Health and Johns Hopkins University, along with six clinical sites, into a prestigious national network of 20 research centers under the Rare Diseases Clinical Research Network. The center focuses on five related genetic conditions — Snyder-Robinson syndrome, DHPS deficiency, Faundes-Banka syndrome and DOHH disorder — within the same biological family, and Bachmann-Bupp syndrome leads the way with regard to treatment progress.

To date, treatment with DFMO through the CPD has successfully reversed key symptoms in five patients worldwide, with 24 children globally now diagnosed with Bachmann-Bupp syndrome. For this pioneering work, Bachmann was named the 2025 Michigan State University Innovator of the Year.

The new $7.6 million grant will help kids like Marley by enabling researchers to:

  • Complete vital clinical research and long-term studies to bring DFMO across the finish line as an FDA-approved treatment for Bachmann-Bupp syndrome, which would make it more accessible for patients, physicians and researchers across the country.
  • Apply lessons learned from exiting treatments to find new diagnostic tools and therapies for four more related rare genetic conditions.
  • Build a global support network by establishing six clinical sites across the country and providing educational tools, screening options and guidance to help pediatricians identify rare symptoms — like sudden hair loss — as early as possible.
  • Train future healthcare leaders by funding pilot studies and training the next generation of doctors and researchers dedicated to caring for rare disease patients.

A heartwarming partnership for patients, physicians and scientists

At the heart of the breakthrough is a deep, personal partnership between laboratory scientists, doctors and parent advocacy groups — such as the Snyder-Robinson Foundation and the nonprofit organization Every Cure, all of whom work side by side to ensure research stays connected to the real-world needs of children and families.

A close-up photograph of 11-year-old Marley Berthoud sitting in her wheelchair, smiling brightly and raising her left hand to wave. She is wearing purple-rimmed eyeglasses and a black t-shirt with white text that reads "RARE disease rockstar." Another person is visible out of focus in the left foreground.
Portrait of Marley Berthoud. Photo credit: Taylor Ballek, Corewell Health.

Beyond the science, this journey remains rooted in the extraordinary bond with the Berthoud family, whose courage paved the way for families around the globe. Today, Marley is an energetic 11-year-old who loves high-fives, spending time with her younger brother Jack, and making sure everyone she meets sees her infectious smile.

“We all want our children to do great things in the world, and she’s doing it at a younger age than a lot of kids,” Kelly said. “She’s had a profound impact on the medical community and the research community just because she was born. I would love for the team at the NIH to know that they entrusted this money to the greatest humans on earth. The world is seeing that they’re changing how medicine works and how research and care can work together.”

MEDIA CONTACTS

Emily Linnert, Kim Ward
Diseases, Conditions and TreatmentsHealth and Medicine

MSUToday Weekly Update

The MSUToday Weekly Update email showcases how Spartans are making a difference through academic excellence, research impact and community outreach. Get inspired by these stories of innovation, collaboration and determination. Plus, enjoy photos and videos of campus and more MSU content to help keep you connected to the Spartan community.

Sign UpUpdate My Information

Connect With Us

Visit our Facebook pageVisit our page on XVisit our Instagram pageVisit our LinkedIn pageVisit our YouTube pageVisit our TikTok page

Resources

  • A to Z Index
  • Find People
  • Maps
  • Email
  • Student Information System (SIS)
  • D2L
  • Libraries
  • Tech Support
  • MSU Misconduct Hotline
  • Social Media Directory
  • Events Calendar
  • For Media

Health and Safety

  • MSU Police and Public Safety
  • Olin Health Center
  • Counseling & Psychiatric Services (CAPS)
  • University Health and Wellbeing
  • MSU Health Care
  • Civil Rights and Title IX
  • Our Commitment
  • Center for Survivors
  • Security & Fire Safety Report
  • University Policy on Relationship Violence and Sexual Misconduct
  • Notice of Non-Discrimination, Anti-Harassment and Non-Retaliation
  • Health Care Non-Discrimination Notice

Support Services

  • Disability Resources
  • Supportive Services
  • Learning Resources

Working at MSU

  • Human Resources
  • EBS Login
  • Job Postings
  • Employee Assistance Program

Reports

  • CARES Act Funding
  • Student Achievement and Outcomes

Contact us

517-355-1855

Address

Michigan State University
426 Auditorium Road
East Lansing, MI 48824

Follow Us

  • Visit our Facebook page
  • Visit our page on X
  • Visit our Instagram page
  • Visit our TikTok page
  • Visit our LinkedIn page
  • Visit our YouTube page

If you're having accessibility issues, please let us know.

Know More: Campus Safety Information and ResourcesTransparency Reporting: Budget & Salary/Compensation
  • Contact Information|
  • Site Map|
  • Privacy Statement|
  • Site Accessibility|
  • Call MSU: (517) 355-1855|
  • Visit: msu.edu|
  • Notice of Nondiscrimination|

SPARTANS WILL|© Michigan State University|

Latest News